Pharmacia Expects Somavert U.S. Approval In "Months"; EU Clears Nov. 13
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Pharmacia anticipates FDA approval of its acromegaly therapy Somavert in the "next several months."